首页 > SCI期刊 > SCIE期刊 > JCRQ3 > 期刊先容
评估信息:
影响因子:1.2
年发文量:19
《综合医学的停顿》(Advances In Integrative Medicine)是一本以INTEGRATIVE & COMPLEMENTARY MEDICINE综合研讨为特点的国际期刊。该刊由Elsevier出书商该刊已被国际主要权势巨子数据库SCIE收录。期刊聚焦INTEGRATIVE & COMPLEMENTARY MEDICINE范畴的重点研讨和前沿停顿,实时刊载和报道该范畴的研讨功效,努力于成为该范畴同业停止疾速学术交换的信息窗口与平台。该刊2023年影响因子为1.2。CiteScore指数值为3.2。
The Journal of Advances in Integrative Medicine is renowned for its high standards of scientific publication and rigorous review process. It adopts an international standard double-blind review system to ensure that each manuscript undergoes rigorous review by professional scholars and experts, ensuring the scientific, innovative, and reliable nature of its content. Its publication scope is extensive, covering multiple fields such as traditional Chinese and Western medicine and dietary therapy, joint research between traditional Chinese medicine and Western medicine, the latest developments in precision medicine, and the impact of genomics on disease prevention and treatment. It comprehensively focuses on the full lifecycle management of diseases, including new technologies, methods, and products related to disease occurrence and development, screening and early warning, diagnostic typing, treatment intervention, and prognosis.
In addition, the journal also focuses on the challenges and opportunities in the global health field, as well as the importance of equal access to healthcare for all, and is committed to promoting the development and popularization of integrated medicine on a global scale. Its international editorial team and open access publishing strategy further promote the widespread dissemination and collaborative exchange of academic achievements.
《综合医学的停顿杂志》以高规范的迷信颁发和严酷的审稿流程著称,接纳国际规范的双盲评审轨制,确保每篇稿件都颠末专业学者和专家的严酷考核,以保障内容的迷信性、立异性和靠得住性。其颁发规模普遍,涵盖中西药与炊事疗法、中医与中医结合研讨、精准医学的最新成长、基因组学对疾病防备和医治的影响等多个范畴,周全存眷疾病的全性命周期办理,包含疾病的产生成长、筛查预警、诊断分型、医治干涉干与及转归预后等方面的新手艺、新体例和新产物。
另外,该期刊还存眷环球卫生范畴的挑衅和机缘,和大家同等享有医疗保健的主要性,努力于鞭策综合医学在环球规模内的成长与提高。其国际化的编委团队和开放取得的出书战略,进一步增进了学术功效的普遍传布与协作交换。
若是您须要辅佐投稿或润稿办事,您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年,熟习颁发政策,可为您供给一对一投稿指点,防止您在投稿时频仍碰鼻,节流您的可贵时候,有用晋升颁发机率,确保SCI检索(检索不了全额退款)。咱们视诺言为性命,多方面确保文章宁静失密,在任何环境下都不会泄漏您的小我信息或稿件内容。
JCR分区品级:Q3
按JIF目标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE | ESCI | Q3 | 28 / 43 |
36% |
按JCI目标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE | ESCI | Q3 | 30 / 43 |
31.4% |
Gold OA文章占比 | 研讨类文章占比 | 文章自引率 |
4.17% | 100.00% | |
开源占比 | 出书国人文章占比 | OA被援用占比 |
名词诠释:JCR分区在学术期刊评估、科研功效展现、科研标的目的指导和学术交换与协作等方面都具备主要的代价。经由过程对期刊影响因子的切确计较和详尽分别,JCR分区可以或许清楚地反应出差别期刊在统一学科范畴内的绝对地位,从而赞助科研职员精确辨认出高品质的学术期刊。
CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||
3.2 | 0.329 | 0.493 |
|
名词诠释:CiteScore是基于Scopus数据库的全新期刊评估系统。CiteScore 2021 的计较体例是期刊比来4年(含计较年度)的被引次数除以该期刊近四年颁发的文献数。CiteScore基于环球最普遍的择要和引文数据库Scopus,合用于一切持续出书物,而不只仅是期刊。今朝CiteScore 收录了跨越 26000 种期刊,比取得影响因子的期刊多13000种。被各界人士以为是影响因子最无力的合作敌手。
积年IF值(影响因子)
积年引文目标和发文量
积年自引数据
若用户须要出书办事,请接洽出书商。